Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GP.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GP.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GP.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
HL.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
HL.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
HL.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HL.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
HL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HL.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HL.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HL.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XCDORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XCDORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XCDORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XCDORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XCDSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XCDNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XCDNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XCDORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XBB.1.44.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-17079.9China
XBB.1.44.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XBB.1.44.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.1.44.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XBB.1.44.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.44.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.44.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.44.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
EG.2.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
EG.2.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
EG.2.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
EG.2.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
EG.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EG.2.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-3925.34Japan
FL.37ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
FL.37ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
FL.37ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FL.37ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
FL.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.37NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.37NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FL.37ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XBB.1.45.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XBB.1.45.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XBB.1.45.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.1.45.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XBB.1.45.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.45.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used